Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rational Combination of CRM1 Inhibitor Selinexor and Olaparib Shows Synergy in Ovarian Cancer Cell Lines and Mouse Models.
Handley KF, Rodriguez-Aguayo C, Ma S, Stur E, Joseph R, Bayraktar E, Dasari SK, Nguyen N, Powell RT, Sobieski M, Ivan C, Kim M, Umamaheswaran S, Glassman D, Wen Y, Amero P, Stephan C, Coleman RL, Landesman Y, Westin SN, Ram PT, Sood AK. Handley KF, et al. Among authors: glassman d. Mol Cancer Ther. 2021 Dec;20(12):2352-2361. doi: 10.1158/1535-7163.MCT-21-0370. Epub 2021 Sep 28. Mol Cancer Ther. 2021. PMID: 34583979 Free PMC article.
Endothelial p130cas confers resistance to anti-angiogenesis therapy.
Wen Y, Chelariu-Raicu A, Umamaheswaran S, Nick AM, Stur E, Hanjra P, Jiang D, Jennings NB, Chen X, Corvigno S, Glassman D, Lopez-Berestein G, Liu J, Hung MC, Sood AK. Wen Y, et al. Among authors: glassman d. Cell Rep. 2022 Jan 25;38(4):110301. doi: 10.1016/j.celrep.2022.110301. Cell Rep. 2022. PMID: 35081345 Free PMC article.
Targeting CCR2+ macrophages with BET inhibitor overcomes adaptive resistance to anti-VEGF therapy in ovarian cancer.
Wu Y, Jennings NB, Sun Y, Dasari SK, Bayraktar E, Corvigno S, Stur E, Glassman D, Mangala LS, Lankenau Ahumada A, Westin SN, Sood AK, Hu W. Wu Y, et al. Among authors: glassman d. J Cancer Res Clin Oncol. 2022 Apr;148(4):803-821. doi: 10.1007/s00432-021-03885-z. Epub 2022 Jan 30. J Cancer Res Clin Oncol. 2022. PMID: 35094142 Free PMC article.
Molecular Correlates of Venous Thromboembolism (VTE) in Ovarian Cancer.
Glassman D, Bateman NW, Lee S, Zhao L, Yao J, Tan Y, Ivan C, Rangel KM, Zhang J, Conrads KA, Hood BL, Abulez T, Futreal PA, Fleming ND, Afshar-Kharghan V, Maxwell GL, Conrads TP, Chen K, Sood AK. Glassman D, et al. Cancers (Basel). 2022 Mar 15;14(6):1496. doi: 10.3390/cancers14061496. Cancers (Basel). 2022. PMID: 35326647 Free PMC article.
Endothelial p130cas confers resistance to anti-angiogenesis therapy.
Wen Y, Chelariu-Raicu A, Umamaheswaran S, Nick AM, Stur E, Hanjra P, Jiang D, Jennings NB, Chen X, Corvigno S, Glassman D, Lopez-Berestein G, Liu J, Hung MC, Sood AK. Wen Y, et al. Among authors: glassman d. Cell Rep. 2022 Jun 21;39(12):110999. doi: 10.1016/j.celrep.2022.110999. Cell Rep. 2022. PMID: 35732127 Free PMC article. No abstract available.
Classification of High-Grade Serous Ovarian Cancer Using Tumor Morphologic Characteristics.
Handley KF, Sims TT, Bateman NW, Glassman D, Foster KI, Lee S, Yao J, Yao H, Fellman BM, Liu J, Lu Z, Conrads KA, Hood BL, Barakat W, Zhao L, Zhang J, Westin SN, Celestino J, Rangel KM, Badal S, Pereira I, Ram PT, Maxwell GL, Eberlin LS, Futreal PA, Bast RC Jr, Fleming ND, Conrads TP, Sood AK. Handley KF, et al. Among authors: glassman d. JAMA Netw Open. 2022 Oct 3;5(10):e2236626. doi: 10.1001/jamanetworkopen.2022.36626. JAMA Netw Open. 2022. PMID: 36239936 Free PMC article.
Exploiting metabolic vulnerabilities after anti-VEGF antibody therapy in ovarian cancer.
Glassman D, Kim MS, Spradlin M, Badal S, Taki M, Bhattacharya P, Dutta P, Kingsley CV, Foster KI, Animasahun O, Jeon JH, Achreja A, Jayaraman A, Kumar P, Nenwani M, Wuchu F, Bayraktar E, Wu Y, Stur E, Mangala L, Lee S, Yap TA, Westin SN, Eberlin LS, Nagrath D, Sood AK. Glassman D, et al. iScience. 2023 Jan 19;26(2):106020. doi: 10.1016/j.isci.2023.106020. eCollection 2023 Feb 17. iScience. 2023. PMID: 36824283 Free PMC article.
Clinical outcomes of leuprolide acetate in the treatment of recurrent ovarian granulosa cell tumors.
Foster KI, Flores Legarreta A, Kamat R, Handley KF, Glassman D, How JA, Lawson BC, Westin SN, Ramondetta LM, Frumovitz M, Gershenson DM, Sood AK, Hillman RT. Foster KI, et al. Among authors: glassman d. Am J Obstet Gynecol. 2023 Jun;228(6):724.e1-724.e9. doi: 10.1016/j.ajog.2023.02.029. Epub 2023 Mar 11. Am J Obstet Gynecol. 2023. PMID: 36907533 Free PMC article.
95 results